We seek to optimize the effectiveness and cost-effectiveness of public health interventions including vaccination and drug treatment.

To achieve this goal, we apply interdisciplinary mathematical modeling approaches to address public health challenges, both nationally and globally, for a wide range of infectious diseases.

Our ongoing research projects within the US include hepatitis C, pneumococcal disease, influenza, human papillomavirus, cytomegalovirus, and pertussis, and our international research projects target Zika virus disease, Ebola virus disease, dengue fever, leprosy, African trypanosomiasis (sleeping sickness), Chagas disease, rabies, and schistosomiasis.